These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
696 related articles for article (PubMed ID: 32653511)
1. Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19. Rogero MM; Leão MC; Santana TM; Pimentel MVMB; Carlini GCG; da Silveira TFF; Gonçalves RC; Castro IA Free Radic Biol Med; 2020 Aug; 156():190-199. PubMed ID: 32653511 [TBL] [Abstract][Full Text] [Related]
2. Specialized pro-resolving mediator network: an update on production and actions. Chiang N; Serhan CN Essays Biochem; 2020 Sep; 64(3):443-462. PubMed ID: 32885825 [TBL] [Abstract][Full Text] [Related]
3. Obesity-Driven Deficiencies of Specialized Pro-resolving Mediators May Drive Adverse Outcomes During SARS-CoV-2 Infection. Pal A; Gowdy KM; Oestreich KJ; Beck M; Shaikh SR Front Immunol; 2020; 11():1997. PubMed ID: 32983141 [TBL] [Abstract][Full Text] [Related]
5. Healthy effect of different proportions of marine ω-3 PUFAs EPA and DHA supplementation in Wistar rats: Lipidomic biomarkers of oxidative stress and inflammation. Dasilva G; Pazos M; García-Egido E; Gallardo JM; Rodríguez I; Cela R; Medina I J Nutr Biochem; 2015 Nov; 26(11):1385-92. PubMed ID: 26320676 [TBL] [Abstract][Full Text] [Related]
6. The need for precision nutrition, genetic variation and resolution in Covid-19 patients. Simopoulos AP; Serhan CN; Bazinet RP Mol Aspects Med; 2021 Feb; 77():100943. PubMed ID: 33551236 [TBL] [Abstract][Full Text] [Related]
7. E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition. Serhan CN; Libreros S; Nshimiyimana R Semin Immunol; 2022 Jan; 59():101597. PubMed ID: 35227568 [TBL] [Abstract][Full Text] [Related]
8. Can Bioactive Lipids Inactivate Coronavirus (COVID-19)? Das UN Arch Med Res; 2020 Apr; 51(3):282-286. PubMed ID: 32229155 [TBL] [Abstract][Full Text] [Related]
9. Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators. Yasmeen N; Selvaraj H; Lakhawat SS; Datta M; Sharma PK; Jain A; Khanna R; Srinivasan J; Kumar V Biochem Pharmacol; 2023 Mar; 209():115437. PubMed ID: 36731803 [TBL] [Abstract][Full Text] [Related]
10. The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection. Gallo CG; Fiorino S; Posabella G; Antonacci D; Tropeano A; Pausini E; Pausini C; Guarniero T; Hong W; Giampieri E; Corazza I; Loiacono R; Loggi E; de Biase D; Zippi M; Lari F; Zancanaro M Prostaglandins Other Lipid Mediat; 2022 Apr; 159():106619. PubMed ID: 35032665 [TBL] [Abstract][Full Text] [Related]
11. Omega-3 fatty acids and inflammatory processes: from molecules to man. Calder PC Biochem Soc Trans; 2017 Oct; 45(5):1105-1115. PubMed ID: 28900017 [TBL] [Abstract][Full Text] [Related]
12. Effects of postnatal omega-3 fatty acid supplementation on offspring pro-resolving mediators of inflammation at 6 months and 5 years of age: A double blind, randomized controlled clinical trial. See VHL; Mas E; Prescott SL; Beilin LJ; Burrows S; Barden AE; Huang RC; Mori TA Prostaglandins Leukot Essent Fatty Acids; 2017 Nov; 126():126-132. PubMed ID: 29031390 [TBL] [Abstract][Full Text] [Related]
13. Over-the-counter fish oil supplementation and pro-resolving and pro-inflammatory lipid mediators in rheumatoid arthritis. Marchand NE; Choi MY; Oakes EG; Cook NR; Stevens E; Gomelskaya N; Kotler G; Manson JE; Lasky-Su J; Mora S; Lee IM; Tatituri R; Costenbader KH Prostaglandins Leukot Essent Fatty Acids; 2023 Mar; 190():102542. PubMed ID: 36773395 [TBL] [Abstract][Full Text] [Related]
14. Genetic Variation, Diet, Inflammation, and the Risk for COVID-19. Simopoulos AP Lifestyle Genom; 2021; 14(2):37-42. PubMed ID: 33530084 [TBL] [Abstract][Full Text] [Related]
15. Dietary supplementation with docosahexaenoic acid, but not eicosapentaenoic acid, dramatically alters cardiac mitochondrial phospholipid fatty acid composition and prevents permeability transition. Khairallah RJ; Sparagna GC; Khanna N; O'Shea KM; Hecker PA; Kristian T; Fiskum G; Des Rosiers C; Polster BM; Stanley WC Biochim Biophys Acta; 2010 Aug; 1797(8):1555-62. PubMed ID: 20471951 [TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney disease. Mas E; Barden A; Burke V; Beilin LJ; Watts GF; Huang RC; Puddey IB; Irish AB; Mori TA Clin Nutr; 2016 Apr; 35(2):331-336. PubMed ID: 25908532 [TBL] [Abstract][Full Text] [Related]
17. Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids. Rupp H; Wagner D; Rupp T; Schulte LM; Maisch B Herz; 2004 Nov; 29(7):673-85. PubMed ID: 15580322 [TBL] [Abstract][Full Text] [Related]
18. Immune-Boosting, Antioxidant and Anti-inflammatory Food Supplements Targeting Pathogenesis of COVID-19. Mrityunjaya M; Pavithra V; Neelam R; Janhavi P; Halami PM; Ravindra PV Front Immunol; 2020; 11():570122. PubMed ID: 33117359 [TBL] [Abstract][Full Text] [Related]
19. Plasma oxylipins respond in a linear dose-response manner with increased intake of EPA and DHA: results from a randomized controlled trial in healthy humans. Ostermann AI; West AL; Schoenfeld K; Browning LM; Walker CG; Jebb SA; Calder PC; Schebb NH Am J Clin Nutr; 2019 May; 109(5):1251-1263. PubMed ID: 31006007 [TBL] [Abstract][Full Text] [Related]
20. Leukotrienes, a potential target for Covid-19. Citron F; Perelli L; Deem AK; Genovese G; Viale A Prostaglandins Leukot Essent Fatty Acids; 2020 Oct; 161():102174. PubMed ID: 32977289 [No Abstract] [Full Text] [Related] [Next] [New Search]